Real-world data and pharmacovigilance reports from FDA databases show a rising number of kidney stone cases in GLP-1 users, particularly in the first 36 months of treatment
SUMO2 and SUMO3 interacted and modified several AR-associated coregulators (p300, SRC2, BAF proteins) and pioneering factors (FOXA1, HOXB13) associated with ARE-bound AR, demonstrating that SUMOylation amplified interactions with its transcriptional complex
Renal And Hepatic Protection: The New Clinical Standard In 2026, semaglutide is no longer viewed solely as a "weight loss drug." The medical community now recognizes its role in protecting vital organs
And my example to my students as always is, you know, if you think you're pre anything, it's like saying you're a little pregnant, you know, you got it